ROIV Latest Headlines

Top Roivant Executive Makes Major Move With Multimillion-Dollar Stock Sale

at www.tipranks.com (Wed, 11-Feb 9:06 PM)

Roivant Sciences Earnings Call Highlights Brepocitinib Surge

at www.tipranks.com (Mon, 9-Feb 7:14 PM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Immunovant (IMVT) and Roivant Sciences (ROIV)

at www.tipranks.com (Sun, 8-Feb 12:20 PM)

ROIV Gains Momentum as Priovant’s Brepocitinib Shows Significant Phase 2 Efficacy in Cutaneous Sarcoidosis

Market Chameleon (Fri, 6-Feb 11:10 AM)

Brepocitinib Delivers Landmark Phase 2 Results in Cutaneous Sarcoidosis—Roivant Solidifies Late-Stage Pipeline Momentum

Market Chameleon (Fri, 6-Feb 7:56 AM)